| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/16/2006 | US20060057739 Method of identification and quantification of proteins, isoforms of the angiotensin i converting enzyme |
| 03/16/2006 | US20060057721 Identifying agents which modulate cell death, indicated by the expression of caspase-2 and/or caspase-7, in Glial cell line-derived neurotrophic factor (GDNF) family growth factor deprived neuronal or nonneuronal cells |
| 03/16/2006 | US20060057720 Mesenchymal cells derived from human embryonic stem cells |
| 03/16/2006 | US20060057703 Method for the evaluation of implantable materials |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057682 Mutation of dna polymerases from archaeobacteria |
| 03/16/2006 | US20060057671 Immobilized probes and methods of detecting conformationally altered prion proteins |
| 03/16/2006 | US20060057670 Genomic markers of hepatitis B virus associated with hepatocellular carcinomas |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057661 comprises peptide, protein, or glycoprotein substrate joined to reporter (dyed latex particle) and magnetic particle, providing cleavage targe for proteolytic enzymes; chromatography; for cancer diagnosis |
| 03/16/2006 | US20060057660 Method for measuring protein NMR |
| 03/16/2006 | US20060057659 Destructible surfactants and uses thereof |
| 03/16/2006 | US20060057658 Labeled substrate conjugates for identifying enzyme inhibitors |
| 03/16/2006 | US20060057657 Stem cell selection and differentiation |
| 03/16/2006 | US20060057653 Detection of microorganisms with holographic sensors |
| 03/16/2006 | US20060057649 Screening method and anti-tumor drug candidate obtained therefrom |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057645 Novel genes |
| 03/16/2006 | US20060057643 Methods and compositions for detecting erythrovirus genotypes |
| 03/16/2006 | US20060057639 CaMKII/calcium channel phosphorylation-related compositions and methods |
| 03/16/2006 | US20060057634 Assay for glycosylated proteins |
| 03/16/2006 | US20060057631 Nano-structured device for analysis or separation, and its preparation and application |
| 03/16/2006 | US20060057630 MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia |
| 03/16/2006 | US20060057629 Device for injecting PCR solution into PCR channels of PCR chip, and PCR chip unit including the device |
| 03/16/2006 | US20060057628 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |
| 03/16/2006 | US20060057626 Assessment of CTLA-4 polymorphisms in CTLA-4 blockade therapy |
| 03/16/2006 | US20060057624 Alternatively spliced pre-mRNA transcripts in neurodegenerative disease |
| 03/16/2006 | US20060057623 SENP1 as a marker of cancer development and target for cancer therapy |
| 03/16/2006 | US20060057622 Low cycle amplification of RNA molecules |
| 03/16/2006 | US20060057621 Assay for detecting tuberculosis in nonhuman primates |
| 03/16/2006 | US20060057620 Treatment of HIV infection |
| 03/16/2006 | US20060057619 Detecting mutations in the proto-oncogene (Met) receptor tyrosine kinase; preventing canine cancers |
| 03/16/2006 | US20060057618 Determining data quality and/or segmental aneusomy using a computer system |
| 03/16/2006 | US20060057617 Amplification process |
| 03/16/2006 | US20060057616 Reverse transcribing RNA to DNA; PCR using outer primer, nested PCR, using inner primers |
| 03/16/2006 | US20060057615 Risk prediction for hypertension, elevated plasma triglyceride and metabolic syndrome |
| 03/16/2006 | US20060057614 Tethering neuropeptides and toxins for modulation of ion channels and receptors |
| 03/16/2006 | US20060057613 Method for distinguishing methicillin resistant S. aureus from methicillin sensitive S. aureus in a mixed culture |
| 03/16/2006 | US20060057612 Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
| 03/16/2006 | US20060057611 Log-linear amplification |
| 03/16/2006 | US20060057610 System for producing synthetic promoters |
| 03/16/2006 | US20060057609 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics |
| 03/16/2006 | US20060057608 Forming a population of nucleic acid sequence tags by covalently coupling target nucleic acids |
| 03/16/2006 | US20060057607 Small RNAs and bacterial strains involved in quorum sensing |
| 03/16/2006 | US20060057606 Reagents containing terminal-phosphate-labeled nucleotides for nucleic acid sequencing |
| 03/16/2006 | US20060057605 Compositions for use in identification of viral hemorrhagic fever viruses |
| 03/16/2006 | US20060057604 Method for electrically detecting oligo-nucleotides with nano-particles |
| 03/16/2006 | US20060057603 Detecting Bacillus anthracis |
| 03/16/2006 | US20060057602 related to testes-specific, vespid and pathogenic proteins (RTVP); metastatic prostatic neoplasia |
| 03/16/2006 | US20060057601 Genomic markers of hepatitis B virus associated with hepatocellular carcinoma |
| 03/16/2006 | US20060057600 Methods for detecting DNA viruses |
| 03/16/2006 | US20060057599 System for autonomous monitoring of bioagents |
| 03/16/2006 | US20060057598 Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma |
| 03/16/2006 | US20060057596 Activity-based assay for ricin-like toxins |
| 03/16/2006 | US20060057595 Compositions, methods, and kits for identifying and quantitating small RNA molecules |
| 03/16/2006 | US20060057593 Method for detecting cystic fibrosis |
| 03/16/2006 | US20060057592 Methods for identifying primase trinucleotide initiation sites and identification of inhibitors of primase activity |
| 03/16/2006 | US20060057591 Method for preventing viral infection |
| 03/16/2006 | US20060057590 RNA probes |
| 03/16/2006 | US20060057589 Identification and detection of algae species, strains and toxins |
| 03/16/2006 | US20060057588 Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma |
| 03/16/2006 | US20060057587 Oligonucleotide arrays comprising background probes |
| 03/16/2006 | US20060057586 Transcript mapping method |
| 03/16/2006 | US20060057585 Nanostepper/sensor systems and methods of use thereof |
| 03/16/2006 | US20060057584 Endometriosis-related markers and uses thereof |
| 03/16/2006 | US20060057583 Novel compositions and methods for controlling the extendability of various components used in copying or amplification steps |
| 03/16/2006 | US20060057582 83 human secreted proteins |
| 03/16/2006 | US20060057581 Microfabricated fluidic device for fragmentation |
| 03/16/2006 | US20060057580 Biochip with maximization of the reactor number |
| 03/16/2006 | US20060057579 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/16/2006 | US20060057578 Determination of an analyte in a liquid medium |
| 03/16/2006 | US20060057577 Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2 |
| 03/16/2006 | US20060057576 Microcapillary hybridization chamber |
| 03/16/2006 | US20060057575 Method for two-dimensional conformation-dependent separation of non-circular nucleic acids |
| 03/16/2006 | US20060057574 Tissue specific expression |
| 03/16/2006 | US20060057573 Methods and reagents for detecting target binding by nucleic acid ligands |
| 03/16/2006 | US20060057572 Designing primers based on information obtained from a part of genes of the specified substance; performing polymerase chain reaction; detecting a trace component contained in a food or identifying a specific harmful allergen |
| 03/16/2006 | US20060057571 Methods for detecting nucleic acids while using solid phase bound primers and cleaving the products of a cyclic amplification reaction (trap release primer amplification (tramp) |
| 03/16/2006 | US20060057570 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 03/16/2006 | US20060057569 Method for detecting hybridization events in nucleic acids |
| 03/16/2006 | US20060057568 Method of identifying compounds that alter bag-1 mediated down-regulation of glucocorticoid-receptor transactivation |
| 03/16/2006 | US20060057566 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques |
| 03/16/2006 | US20060057565 Combinatorial fluorescence energy transfer tags and uses thereof |
| 03/16/2006 | US20060057564 oligonucleotide probes which can discriminate between alleles of nucleic acid in assays; linkage studies in families and disequilibrium in isolated populations |
| 03/16/2006 | US20060057563 Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof |
| 03/16/2006 | US20060057562 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 03/16/2006 | US20060057561 Virus detection method, primers therefor and screening kit |
| 03/16/2006 | US20060057560 System and method for denaturing and fixing collagenous tissue |
| 03/16/2006 | US20060057559 High-throughput cell migration screening assay |
| 03/16/2006 | US20060057558 Maintaining a piece of skin in culture medium, applying test materials to the surface of the skin, measuring the effect of the topically applied material |
| 03/16/2006 | US20060057557 Method for identifying an image of a well in an image of a well-bearing component |
| 03/16/2006 | US20060057556 Contiguous capillary electrospray sources and analytical devices |
| 03/16/2006 | US20060057555 Method and system for controlling the development of biological entities |
| 03/16/2006 | US20060057554 Sample collecting device and mass spectrometry of device |
| 03/16/2006 | US20060057553 Chimeric viral vectors for gene therapy |
| 03/16/2006 | US20060057250 Method for selecting lipolytic enzyme |
| 03/16/2006 | US20060057164 Isolated, purified polynucleotides, expression vector, host cells, antibodies; mutation functionally disrupting catalytic domain |
| 03/16/2006 | US20060057161 Detection of coronavirus infection |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |